These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31584692)

  • 1. Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry.
    Kraft M; Knop MP; Renaudin JM; Scherer Hofmeier K; Pföhler C; Bilò MB; Lang R; Treudler R; Wagner N; Spindler T; Hourihane JO; Maris I; Koehli A; Bauer A; Lange L; Müller S; Papadopoulos NG; Wedi B; Moeser A; Ensina LF; Fernandez-Rivas M; Cichocka-Jarosz E; Christoff G; Garcia BE; Poziomkowska-Gęsicka I; Cardona V; Mustakov TB; Rabe U; Mahler V; Grabenhenrich L; Dölle-Bierke S; Worm M;
    Allergy; 2020 Apr; 75(4):901-910. PubMed ID: 31584692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAACI Task force Clinical epidemiology of anaphylaxis: experts' perspective on the use of adrenaline autoinjectors in Europe.
    Kraft M; Dölle-Bierke S; Turner PJ; Muraro A; Fernández-Rivas M; Grabenhenrich L; Worm M
    Clin Transl Allergy; 2020; 10():12. PubMed ID: 32426107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry.
    Grabenhenrich LB; Dölle S; Moneret-Vautrin A; Köhli A; Lange L; Spindler T; Ruëff F; Nemat K; Maris I; Roumpedaki E; Scherer K; Ott H; Reese T; Mustakov T; Lang R; Fernandez-Rivas M; Kowalski ML; Bilò MB; Hourihane JO; Papadopoulos NG; Beyer K; Muraro A; Worm M
    J Allergy Clin Immunol; 2016 Apr; 137(4):1128-1137.e1. PubMed ID: 26806049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine autoinjector prescription patterns for severe anaphylactic patients in Japan: A retrospective analysis of health insurance claims data.
    Nakajima M; Ono S; Michihata N; Kaszynski RH; Matsui H; Yamaguchi Y; Yasunaga H
    Allergol Int; 2020 Jul; 69(3):424-428. PubMed ID: 32253115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAACI guidelines: Anaphylaxis (2021 update).
    Muraro A; Worm M; Alviani C; Cardona V; DunnGalvin A; Garvey LH; Riggioni C; de Silva D; Angier E; Arasi S; Bellou A; Beyer K; Bijlhout D; Bilò MB; Bindslev-Jensen C; Brockow K; Fernandez-Rivas M; Halken S; Jensen B; Khaleva E; Michaelis LJ; Oude Elberink HNG; Regent L; Sanchez A; Vlieg-Boerstra BJ; Roberts G;
    Allergy; 2022 Feb; 77(2):357-377. PubMed ID: 34343358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of adrenaline autoinjectors by children and teenagers.
    Noimark L; Wales J; Du Toit G; Pastacaldi C; Haddad D; Gardner J; Hyer W; Vance G; Townshend C; Alfaham M; Arkwright PD; Rao R; Kapoor S; Summerfield A; Warner JO; Roberts G
    Clin Exp Allergy; 2012 Feb; 42(2):284-92. PubMed ID: 22181034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry.
    Worm M; Francuzik W; Renaudin JM; Bilo MB; Cardona V; Scherer Hofmeier K; Köhli A; Bauer A; Christoff G; Cichocka-Jarosz E; Hawranek T; Hourihane JO'; Lange L; Mahler V; Muraro A; Papadopoulos NG; Pföhler C; Poziomkowska-Gęsicka I; Ruëff F; Spindler T; Treudler R; Fernandez-Rivas M; Dölle S
    Allergy; 2018 Jun; 73(6):1322-1330. PubMed ID: 29318637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ability to Use Epinephrine Autoinjector in Patients Who Receive Prescription Immediately after Anaphylaxis.
    Kadivec S; Košnik M
    Int Arch Allergy Immunol; 2021; 182(7):625-630. PubMed ID: 33486490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of anaphylaxis management guidelines: a register-based study.
    Grabenhenrich L; Hompes S; Gough H; Ruëff F; Scherer K; Pföhler C; Treudler R; Mahler V; Hawranek T; Nemat K; Koehli A; Keil T; Worm M
    PLoS One; 2012; 7(5):e35778. PubMed ID: 22590513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry.
    Aurich S; Dölle-Bierke S; Francuzik W; Bilo MB; Christoff G; Fernandez-Rivas M; Hawranek T; Pföhler C; Poziomkowska-Gȩsicka I; Renaudin JM; Oppel E; Scherer K; Treudler R; Worm M
    Front Immunol; 2019; 10():750. PubMed ID: 31068925
    [No Abstract]   [Full Text] [Related]  

  • 11. Adherence to Anaphylaxis Guidelines: Real-World Data From the Emergency Department of a Tertiary Hospital.
    Ponce Guevara LV; Laffond Yges E; Gracia Bara MT; Moreno Rodilla E; Muñoz Bellido FJ; Lázaro Sastre M; Macías Iglesias EM; de Arriba Méndez S; Campanón Toro MV; Dávila Gónzalez I
    J Investig Allergol Clin Immunol; 2018; 28(4):246-252. PubMed ID: 29465401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector.
    Fromer L
    Am J Med; 2016 Dec; 129(12):1244-1250. PubMed ID: 27555092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register.
    Grabenhenrich LB; Dölle S; Ruëff F; Renaudin JM; Scherer K; Pföhler C; Treudler R; Koehli A; Mahler V; Spindler T; Lange L; Bilò MB; Papadopoulos NG; Hourihane JOB; Lang R; Fernández-Rivas M; Christoff G; Cichocka-Jarosz E; Worm M
    J Allergy Clin Immunol Pract; 2018; 6(6):1898-1906.e1. PubMed ID: 29606638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epinephrine autoinjector availability among children with food allergy.
    DeMuth KA; Fitzpatrick AM
    Allergy Asthma Proc; 2011; 32(4):295-300. PubMed ID: 21781405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).
    Gold MS; Sainsbury R
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):171-6. PubMed ID: 10887321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia.
    Loke P; Koplin J; Beck C; Field M; Dharmage SC; Tang ML; Allen KJ
    J Allergy Clin Immunol; 2016 Aug; 138(2):529-35. PubMed ID: 27084405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action Plan to Ensure Global Availability of Adrenaline Autoinjectors.
    Tanno LK; Demoly P;
    J Investig Allergol Clin Immunol; 2020 Apr; 30(2):77-85. PubMed ID: 32327400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First European data from the network of severe allergic reactions (NORA).
    Worm M; Moneret-Vautrin A; Scherer K; Lang R; Fernandez-Rivas M; Cardona V; Kowalski ML; Jutel M; Poziomkowska-Gesicka I; Papadopoulos NG; Beyer K; Mustakov T; Christoff G; Bilò MB; Muraro A; Hourihane JO; Grabenhenrich LB
    Allergy; 2014 Oct; 69(10):1397-404. PubMed ID: 24989080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals.
    Mahoney B; Walklet E; Bradley E; O'Hickey S
    Immun Inflamm Dis; 2019 Sep; 7(3):214-228. PubMed ID: 31290265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study.
    Gaziel Yablowitz M; Dölle S; Schwartz DG; Worm M
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13414. PubMed ID: 31441432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.